Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4 - Wikidata - wikimedia - TriplyDB

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

http://www.wikidata.org/entity/Q36161477

about

Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes Designer probiotics: Development and applications in gastrointestinal health Advances in HIV microbicide development Microbicides: a new hope for HIV prevention Rational design of improved pharmabiotics The highly autoaggregative and adhesive phenotype of the vaginal Lactobacillus plantarum strain CMPG5300 is sortase dependent Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors.Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.New approaches to making the microenvironment of the female reproductive tract hostile to HIV.Protective Effects of Cell-Free Supernatant and Live Lactic Acid Bacteria Isolated from Thai Pigs Against a Pandemic Strain of Porcine Epidemic Diarrhea Virus.Which topical microbicides for blocking HIV-1 transmission will work in the real world?sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates.Targeting Trojan Horse leukocytes for HIV prevention.Sustained delivery of commensal bacteria from pod-intravaginal rings.Development of an HIV-1 specific microbicide using Caulobacter crescentus S-layer mediated display of CD4 and MIP1alpha An anti-HIV microbicide comes alive Coexpression and secretion of endoglucanase and phytase genes in Lactobacillus reuteri.Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.Genetic approaches to interfere with malaria transmission by vector mosquitoes Transformation of, and heterologous protein expression in, Lactobacillus agilis and Lactobacillus vaginalis isolates from the chicken gastrointestinal tract.Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide Identification and characterisation of vaginal lactobacilli from South African women.Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.Vaginal microbiota and its role in HIV transmission and infection.Secretion of anti-Plasmodium effector proteins from a natural Pantoea agglomerans isolate by using PelB and HlyA secretion signals The gastrointestinal microbiome: a malleable, third genome of mammals.A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development.Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.HIV-1 entry inhibitors: closing the front door.Host-flora interactions in inflammatory bowel disease.A special fondness for lactobacilli.Inhibition of Plasmodium berghei Development in Mosquitoes by Effector Proteins Secreted from Asaia sp. Bacteria Using a Novel Native Secretion Signal Evolving issues in understanding and treating bacterial vaginosis.Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut.Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.Delivery of therapeutic proteins to the mucosa using genetically modified microflora.

P2860

Q24535758-0A5EDA47-89AD-4080-86D5-91103EF9B027 Q24620129-A4E9A42F-A2B3-47A3-AF6C-C451224B0B09 Q26786083-7CF95E3D-462E-4D67-89E2-8A90843D1F4D Q26795388-99F22CE2-7338-42CE-96F2-601733734791 Q26852858-E95FE970-EC9E-4E4D-A83B-3939ABD4577C Q27022779-9B1D33CE-B573-48C2-8CFA-09C8441CC855 Q28258559-1E7F7442-AB79-4909-A384-E60DEAA83F17 Q28675693-F7FE131B-1AF7-43BC-A66B-89E170561862 Q30351993-2DD2F5DA-5052-42B4-9D50-3B2CCF38D3B1 Q30357096-1CF7668E-0A4D-4616-9384-30FC9F4F6BAE Q30378613-4E06C72D-66A6-4168-B37A-7F2A0DEA4B79 Q30398454-04F3AACC-11AE-49B8-8BD3-A277672BDBE2 Q30401289-99A1185A-0D06-4CEC-9074-5699343F9028 Q33253661-CB7C752F-430E-4047-9816-1798BE3AA7CD Q33348658-5B55EFFE-12C0-4364-8F76-F2D60F906D69 Q33518390-208C26D6-F3E6-46FF-8DB0-37CCC3F81616 Q33622882-D6920491-DB69-4814-A869-B3E3524769C5 Q33815944-74CEE2D6-DD2F-4839-B15C-38898D9A24E1 Q33934017-BF3FD548-32DA-4B1F-A7F9-6CC726895E53 Q34072533-9F1851D5-A993-4975-91E9-9EABDDD8A9E9 Q34172623-DD5CCED5-9E21-425D-A387-C374107D9513 Q34198191-C20090BB-6A57-4613-BA9F-A8CC3ACCC29D Q34326992-FE5B07A0-B062-42B8-BC2D-EFD6E12B9FEC Q34483830-E1E803F5-D7B8-4A34-BCFC-84DD01DBEE82 Q34539354-BB901EEA-3382-41E6-8091-3B8BBA601E9B Q34564029-4AF9B932-FEF2-4125-B616-1969871BA632 Q34629039-7AF9FAED-F6B3-4A68-8A72-964B5821F0E2 Q34780332-BE20E29C-8D27-4B04-A833-1D6F72D3A04E Q35080925-9CB176CB-1110-4534-B922-0A1628FB73D5 Q35214930-EDE1FFA3-5DE3-423D-8DED-4414536D83BA Q35575950-6887AFE9-D461-4904-B85F-CF43C31269E4 Q35598601-C869CE47-805E-4AE6-A12B-E7D2956EE9BE Q35753350-0D3646E5-188F-4338-AB1D-2A44E0CA48F3 Q35787630-8EC0B0BA-36CF-4497-BFE9-432BFE46CD02 Q35796596-6459DB16-A713-4A51-B8B4-AB41C0622E0E Q35860846-8A89B1E8-EF7F-473C-B9C1-78D02FCBEFE5 Q35964759-9517990E-320E-4ED6-B7C9-74A7497A79A5 Q35976909-A053779B-B711-4E98-B216-CC19F0AEDDD0 Q36231045-410669F6-1600-4587-9268-1F4435D6D4EF Q36316890-DD3EEF38-119B-4662-9652-52BB471D6B06

P2860

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

http://www.wikidata.org/entity/Q36161477

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@ast

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@en

type

label

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@ast

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@en

prefLabel

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@ast

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@en

P1433

Q36161477-69DC9733-7EB3-42D6-909E-F53B5B3DF2A2

P1476

Q36161477-1F636D46-61F4-4516-89E1-8DE5A8DEA033

P2093

Q36161477-12CAA663-F9E3-4FE6-BE34-52A582ADDE7C

Q36161477-189BCBD7-5674-4CD0-8BD7-A17E9DEE6010

Q36161477-366836B4-7786-43EE-A134-86EC18FB15BE

Q36161477-64C30B0A-14DB-4743-924E-2E5F3E3E6BF6

Q36161477-8D619F03-8313-438F-A86D-384D4039CFC3

Q36161477-AEA8FA2A-9448-43C0-B4BE-169D7B4D2AC9

Q36161477-C6AA9D4C-8B4E-49F1-AD13-A52D819CE0A8

Q36161477-C7734AAA-91B5-4B9C-9BB0-F3EA35D0CEB5

Q36161477-DAE3DA44-971F-431B-AD48-BB637C235E4A

Q36161477-EB80CD70-6CF3-41E2-BA36-59E16E593B22

P2860

Q36161477-0C949BB8-B044-4D55-98FE-97983942192C

Q36161477-19E9CA22-FA40-48D3-8DD8-DFC7680417C5

Q36161477-1EC5D694-026F-4E5C-A410-8168A8D4D532

Q36161477-2372808E-6DC7-4F1A-8885-2127601A3D76

Q36161477-23FA58BC-5E7C-49FA-9670-4B379555794A

Q36161477-27907BD3-0C0F-4C75-9EA2-7B84A341E758

Q36161477-35876A20-AD47-4DA7-A81E-BC38E928C3B4

Q36161477-3EB14349-60C5-448D-B6F4-26232602083F

Q36161477-409F4FFB-367E-4661-9E8C-C11C7FD1CA1D

Q36161477-52B70B30-89B7-4BB9-9BA9-B8336D1F394B

P304

Q36161477-7E2FC01E-8009-4C5D-98C7-B9BAB56D7ABA

P31

Q36161477-8145AAED-6650-47A6-B2AB-76B096E0CF1E

P356

Q36161477-A3739737-28A7-4AFF-849B-DFAC1B3F55AB

P407

Q36161477-3FF03EFF-B4B4-4FCD-A893-D1338C3662BF

P433

Q36161477-2710EC9F-4692-4F5D-A68E-0B663F7A37E6

P478

Q36161477-C02D4187-9F87-4959-BF12-D9DE0C92D8CC

P50

Q36161477-B1405D66-F975-4301-A3AC-AF0BD5CC3A25

P577

Q36161477-8A930F02-6867-409D-BC19-CFE19680A1B6

P5875

Q36161477-A281F8DB-F158-454C-97B2-0A34903BA164

P698

Q36161477-BEDB4410-FDC4-402C-91E6-2829C7FB6187

P932

Q36161477-DC14424B-5B56-4DAF-9AE6-FD66DDAB3303

P356

PNAS.1934747100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inhibition of HIV infectivity ...... ress functional two-domain CD4

@en

P2093

Chia-Hwa Chang

http://www.w3.org/2001/XMLSchema#string

David A Simpson

http://www.w3.org/2001/XMLSchema#string

David D Ho

http://www.w3.org/2001/XMLSchema#string

Gary K Schoolnik

http://www.w3.org/2001/XMLSchema#string

John A Lewicki

http://www.w3.org/2001/XMLSchema#string

Laurel A Lagenaur

http://www.w3.org/2001/XMLSchema#string

Patrick K Martin

http://www.w3.org/2001/XMLSchema#string

Peter P Lee

http://www.w3.org/2001/XMLSchema#string

Qiang Xu

http://www.w3.org/2001/XMLSchema#string

Sharon L Hillier

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial biofilms: a common cause of persistent infections

The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides

A brief sexual barrier intervention for women living with AIDS: acceptability, use, and ethnicity

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Protein design of an HIV-1 entry inhibitor.

Efficiency of transcription from promoter sequence variants in Lactobacillus is both strain and context dependent

Acquired antibiotic resistance in lactic acid bacteria from food.

P304

11672-11677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1934747100

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10568323

http://www.w3.org/2001/XMLSchema#string

P698

12972635

http://www.w3.org/2001/XMLSchema#string

P932

208816

http://www.w3.org/2001/XMLSchema#string